 Investors in Clovis Oncology NASDAQ: CLVS stock will want to prepare for a bankruptcy filing following a warning from the pharmaceutical company. According to a filing with the U.S. Securities and Exchange Commission SEC, the company is expecting to file for Chapter 11 bankruptcy protection. 